Eran Ovadya
Director of Finance/CFO at NUREXONE BIOLOGIC INC.
Net worth: - $ as of 30/04/2024
Profile
Mr. Eran Ovadya is a Chief Financial Officer at NurExone Biologic, Inc. Mr. Ovadya was previously employed as a Chief Financial Officer by Silexion Therapeutics Ltd.
and a Chief Financial Officer by VVT Medical Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUREXONE BIOLOGIC INC
-.--% | 08/05/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Eran Ovadya active positions
| Companies | Position | Start |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Director of Finance/CFO | 15/06/2022 |
Former positions of Eran Ovadya
| Companies | Position | End |
|---|---|---|
| VVT Medical Ltd. | Director of Finance/CFO | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Private companies | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
- Stock Market
- Insiders
- Eran Ovadya
